Geron Corporation (GERN) has experienced challenges in growth. The company operates in the Healthcare sector, specifically in the Biotechnology industry.
Historical revenue and profitability trends for Geron Corporation
The chart above illustrates Geron Corporation's revenue trajectory over the past 4 years. The revenue pattern shows the challenges the company has faced in recent periods.
Annual percentage change in revenue and earnings
Growth rates provide insight into the momentum of Geron Corporation's business.
How efficiently Geron Corporation converts revenue into profit
Profit margins reveal how much of each dollar of revenue Geron Corporation retains at different stages:
Analyst estimates and forward-looking indicators
Wall Street analysts project Geron Corporation to continue growing earnings in the coming year. The consensus analyst rating is 4.1111 based on 9 analysts.
Based on our comprehensive analysis, Geron Corporation (GERN) demonstrates declining growth characteristics.
This growth analysis provides a comprehensive view of Geron Corporation's historical performance and future outlook. Investors should consider these growth metrics alongside valuation, competitive positioning, and broader market conditions when making investment decisions. Past performance does not guarantee future results.
See how Geron Corporation stacks up against similar companies
Explore growth analysis for top stocks
Related: GERN Valuation, GERN Dividend, GERN Financial Health
Compare: GERN vs AAPL, GERN vs MSFT, GERN vs GOOGL